Linden Advisors’s Cano Health, Inc. CANO Stock Holding History

Linden Advisors’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,854	Closed	-$17.5M	–	507
2020 Q3	$17.5M	Buy	+16,854	New	+$17.6M	0.21%	86

Other funds holding CANO

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Diameter Capital Partners New York $1.24B AUM 137.67% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Linden Advisors's CANO Position: Q4 2020 in Review

Linden Advisors sold out of Cano Health, Inc. (CANO) in Q4 2020, closing a stake of 16,854 shares — an estimated $17.5M sold.

Linden Advisors first reported a position in CANO in Q3 2020 and held it in 1 quarter. The position peaked at $17.5M in Q3 2020. 81 funds tracked by Wall St. Rank hold CANO as of Q4 2020.

Linden Advisors reported no remaining Cano Health, Inc. position as of Q4 2020 after selling out during the quarter.
Linden Advisors sold 16,854 Cano Health, Inc. shares in Q4 2020, an estimated $17.5M.
Linden Advisors first reported a position in Cano Health, Inc. in Q3 2020 and held it in 1 quarter.
Linden Advisors's Cano Health, Inc. position peaked at $17.5M in Q3 2020.
81 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2020.

Based on Linden Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.